RemedyRepack Inc. is recalling three bottles of Amlodipine/Valsartan/HCTZ (10mg/320mg/25mg) tablets, a prescription medication used to treat high blood pressure. This recall affects approximately 270 tablets packaged in 90-count HDPE bottles. The recall was initiated because trace amounts of N-nitrosodimethylamine (NDMA) were detected in the active pharmaceutical ingredient; NDMA is a substance that could potentially cause cancer in humans. Consumers should contact their healthcare provider or pharmacist immediately to discuss alternative treatments before stopping the medication.
The medication contains trace amounts of NDMA, a known environmental contaminant and probable human carcinogen. Long-term exposure to levels of NDMA above acceptable limits may increase the risk of developing cancer.
Healthcare guidance and product refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.